Previous reports have shown that RUNX3 expression was reduced in numerous types of human cancers, such as breast cancer, colorectal cancer, renal cell carcinoma, melanoma [8], [11], [13], [18]. This evidence concerns the gene RUNX3 and colorectal cancer.